Our Adherence Risk Management (ARM) is supported by an online platform, is scalable, easy to use, and easy to implement.
Today everyone is aware of the devastating effects non-adherence to treatment in clinical care has on patients, healthcare systems, and to a larger extent society as a whole. Annually, it leads to 200.000 premature deaths and €125 billion in avoidable healthcare costs. And these are only EU figures. For other regions, there is similar data.
In clinical research, our industry has always been under the impression that non-adherence was not such a major issue. But we were simply ignoring the tell-tale signs. A 30% average and ongoing early drop-out rate is such a sign. And almost 70% of the protocol deviations possibly linked to non-adherence is another sign. Imagine the effects this has on timelines, costs, efficacy, and your clinical dataset!
In 2017 we realized that adherence is very much about human behavior and decided to take a leap forward by developing our Adherence Risk Management (ARM) services based on behavioral science. At the core of ARM is the Subjective Experienced Health Model (SEHM) developed by Bloem & Stalpers. SEHM is disease-agnostic, proven, and easy to use and enables us to provide dynamic, personalized patient support during clinical studies. And at the same time support your sites with actionable information on the adherence status of patients!
1. Identify the top risk factors of non-adherence for your clinical study
2. Develop communications and support packages for each ARM profile targeting trial events and risk factors. These packages are designed to motivate and improve adherent behavior.
1. Identify the ARM profile of each patient
2. Push the right information and support to each patient, based on their up-to-date ARM profile. Each patient will:
a. Get the right information in the right form
b. Get the right level of support at the right time
c. Feel acknowledged, appreciated, and
treated as an individual again
3. Send alerts to the clinical trial team if and when a patient’s ARM profile moves into the high-risk zone.
Tell us more. Solutions from Link2Trials go one step further. Let us know your goals